The Preclinical Drug Development provides a comprehensive suite of preclinical research services designed to support the development of pharmaceutical drugs, vaccines, and phytomedicines. As a national research facility, we partner with industry, research institutions, and academic collaborators to deliver high-quality, scientifically robust, and ethically compliant studies.

Our integrated service offering spans early-stage discovery through to advanced preclinical evaluation, enabling clients to generate reliable data that informs critical decision-making in the drug development pipeline.

Through specialised expertise, state-of-the-art facilities, and established scientific methodologies, we support a wide range of studies including toxicity evaluation, pharmacokinetics, efficacy testing, and disease modelling. Our services are tailored to meet specific project requirements, ensuring flexibility, precision, and alignment with both regulatory and research standards.
In addition to technical excellence, we are committed to fostering long-term partnerships by providing collaborative support, transparent communication, and efficient project delivery.